Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ángel

Ángel Arévalo Martín, Toledo ES

Patent application numberDescriptionPublished
20120015945USE OF CB1 ANTAGONISTS AND/OR INVERSE AGONISTS FOR THE PREPARATION OF DRUGS THAT INCREASE MOTOR NEURON EXCITABILITY - Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.01-19-2012

Ángel Chamorro Sánchez, Barcelona ES

Patent application numberDescriptionPublished
20120108532PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE TREATMENT IN PATIENTS WITH ICTUS COMPRISING CITICOLINE AND URIC ACID - A pharmaceutical composition comprised of uric acid and citicoline is for the neuroprotective treatment of patients with ictus.05-03-2012

Ángel De Marcos Serrano, Getafe (madrid) ES

Patent application numberDescriptionPublished
20110119886METHOD FOR DESIGNING AND MANUFACTURING MODEL PIECES OF VARIABLE CONFIGURATION - It is applied in those processes in which it is required to modify the configuration of a first piece (05-26-2011

Ángel Lozano Sicilia, Madrid ES

Patent application numberDescriptionPublished
20120015945USE OF CB1 ANTAGONISTS AND/OR INVERSE AGONISTS FOR THE PREPARATION OF DRUGS THAT INCREASE MOTOR NEURON EXCITABILITY - Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.01-19-2012

Ángel Martínez-Garrido Martínez, Paterna ES

Patent application numberDescriptionPublished
20120136237COMPACT, HYBRID AND INTEGRATED GAMMA/RF SYSTEM USED TO FORM SIMULTANEOUS PET OR SPECT AND MR IMAGES - The GAMMA/RF compact, hybrid and integrated system for PET-SPECT/MR simultaneous imaging of the invention comprises a GAMMA/RF device that integrates an RF coil, of the type used in conventional MR systems, with GAMMA radiation detector modules of the type used in PET or SPECT systems, so that combined PET or SPECT and MR images are obtained.05-31-2012

Ángel Mérida Berlanga, Pamplona ES

Patent application numberDescriptionPublished
20120102597METHOD FOR THE PRODUCTION OF TRANSGENIC PLANTS HAVING HIGH STARCH AND BIOMASS CONTENT AND YIELD - Process for the production of transgenic plants that have high content and yield of starch and biomass. The starch synthases (SSs) in plants (including SSIV) and glycogen synthase (GlgA) in bacteria catalyse the transfer of the glucosidic part of the ADP-Glucose molecule (the activated donor of glucose) to a pre-existing α(1, 4)-glucan. However, in contrast to the other SSs, SSIV is able to add glucose units to maltotriose. Also, in contrast to other soluble SSs, SSIV is bound to the starch granule. This invention describes for the first time how to obtain plants that have high levels and yields of starch and biomass as a consequence of the expression of genes coding for SSIV.04-26-2012

Ángel Merlos Domingo, Barcelona ES

Patent application numberDescriptionPublished
20100193378IMPEDIMETRIC SENSOR AND APPLICATIONS THEREOF - The invention relates to a highly sensitive impedimetric sensor in which the highly conductive electrodes are separated by a barrier of insulating material. Said sensor is used to determine directly the presence of analytes in a biological sample of human, veterinary or environmental origin.08-05-2010

Ángel Merlos Domingo, Barcelona ES

Patent application numberDescriptionPublished
20100193378IMPEDIMETRIC SENSOR AND APPLICATIONS THEREOF - The invention relates to a highly sensitive impedimetric sensor in which the highly conductive electrodes are separated by a barrier of insulating material. Said sensor is used to determine directly the presence of analytes in a biological sample of human, veterinary or environmental origin.08-05-2010

Ángel Messeguer Peypoch, Barcelona ES

Patent application numberDescriptionPublished
20100247587PIGMENTATION-REGULATING COMPOUNDS - The present invention relates to compounds of general formula (I):09-30-2010

Ángel Messeguer Peypoch, Barcelona ES

Patent application numberDescriptionPublished
20100247587PIGMENTATION-REGULATING COMPOUNDS - The present invention relates to compounds of general formula (I):09-30-2010
20110160189COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES - The invention relates to a compound (I) wherein R is a heterocyclyl radical; R06-30-2011

Ángel Messeguer Pyepoch, Barcelona ES

Patent application numberDescriptionPublished
20120122868APAF-1 INHIBITOR COMPOUNDS - Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis.05-17-2012

Ángel Pey Rodríguez, Zaragoza ES

Patent application numberDescriptionPublished
20100286166COMPOSITIONS FOR THE TREATMENT OF HYPERPHENYLALANINEMIA - The present invention relates to the use of specific types of compounds acting as pharmacological chaperones having a stabilizing activity on the phenylalanine hydroxylase (PAH) enzyme for the prophylaxis and/or treatment of hyperphenylalaninemia (HPA) and phenylketonuria PKU) and diseases, disorders and conditions related thereto. Further, the present invention relates to pharmaceutical compositions containing the compounds according to the present invention as well as to methods of treatment of HPA, in particular, PKU and diseases, disorders and conditions related thereto.11-11-2010

Ángel Pey Rodríguez, Zaragoza ES

Patent application numberDescriptionPublished
20100286166COMPOSITIONS FOR THE TREATMENT OF HYPERPHENYLALANINEMIA - The present invention relates to the use of specific types of compounds acting as pharmacological chaperones having a stabilizing activity on the phenylalanine hydroxylase (PAH) enzyme for the prophylaxis and/or treatment of hyperphenylalaninemia (HPA) and phenylketonuria PKU) and diseases, disorders and conditions related thereto. Further, the present invention relates to pharmaceutical compositions containing the compounds according to the present invention as well as to methods of treatment of HPA, in particular, PKU and diseases, disorders and conditions related thereto.11-11-2010

Ángel Rodríguez Bartolomé, Madrid ES

Patent application numberDescriptionPublished
20100086905SIMULATION SYSTEM FOR ARTHROSCOPIC SURGERY TRAINING - The invention relates to a simulator for training in arthroscopic surgery on a joint of a simulated patient, comprising: a data processing unit (04-08-2010

Ángel Rodríguez Bartolomé, Madrid ES

Patent application numberDescriptionPublished
20100086905SIMULATION SYSTEM FOR ARTHROSCOPIC SURGERY TRAINING - The invention relates to a simulator for training in arthroscopic surgery on a joint of a simulated patient, comprising: a data processing unit (04-08-2010

Ángel Rumbero Sánchez, Armilla-Granada ES

Patent application numberDescriptionPublished
20110319484NEUROPROTECTIVE COMPOUNDS - The invention describes the use of (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl-1-naphthalenyl propanoate derivatives, optionally mono- or di-methylated at the carbon in the alpha position of propanoic acid, of formula (I), where R is CH12-29-2011
20120095091ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND - The present invention describes a compound of formula (I)04-19-2012

Ángel Sebastiá Cortés, Valencia ES

Patent application numberDescriptionPublished
20120136237COMPACT, HYBRID AND INTEGRATED GAMMA/RF SYSTEM USED TO FORM SIMULTANEOUS PET OR SPECT AND MR IMAGES - The GAMMA/RF compact, hybrid and integrated system for PET-SPECT/MR simultaneous imaging of the invention comprises a GAMMA/RF device that integrates an RF coil, of the type used in conventional MR systems, with GAMMA radiation detector modules of the type used in PET or SPECT systems, so that combined PET or SPECT and MR images are obtained.05-31-2012